Synthetic bone graft substitutes

ANZ Journal of Surgery

Volumn 71, Issue 6, 2001, Pages 354-361

  Moore, William R ^a   Graves, Stephen E ^b   Bain, Gregory I ^c  

^a MODBURY HOSPITAL   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Allograft; Autograft; Bone graft substitute; Future

Indexed keywords

ALUMINUM OXIDE; BETA-TRICALCIUM PHOSPHATE; BIOMATERIAL; BONE CEMENT; CALCIUM PHOSPHATE; CALCIUM SULFATE; HYDROXYAPATITE;

BONE PROSTHESIS; BONE REGENERATION; BONE TRANSPLANTATION; HUMAN; METHODOLOGY; REVIEW;

ALUMINUM OXIDE; BIOCOMPATIBLE MATERIALS; BONE CEMENTS; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; CALCIUM SULFATE; DURAPATITE; HUMANS; HYDROXYAPATITES;

EID: 0035380036     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.2001.02128.x     Document Type: Review

References (66)

1. Constantino PD, Freidman CD. Synthetic bone graft substitutes. Otolaryngol. Clin. North Am. 1994; 27: 1037-73.
2. Cypher TJ, Grossman JP. Biological principles of bone graft healing. J. Foot Ankle Surg. 1996; 35: 413-17.
3. Triffitt JT. The stem cell of the osteoblast. In: Bilizekian J, Raisz L, Rodou G (eds) Principles of Bone Biology. San Diego, CA: Academic, 1996; 39-50.
4. Kurz LT, Garfin SR, Booth JR. Harvesting autogenous iliac bone grafts: A review of complications and techniques Spine 1989; 14: 1324-31.
5. Fernyhough JC, Schimandle JJ, Weigel MC. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine 1992; 17: 1474-80.
6. Mankin HJ, Gebhardt MC. Long term results of allograft replacement in the management of bone tumours. Clin. Orthop. 1996; 324: 86-97.
7. Simonds RJ, Holmberg SD, Hurwitz RL et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N. Engl. J. Med. 1992; 326: 726-32.
8. Sanan A, Haines SJ. Repairing holes in the head: A history of cranioplasty. Neurosurgery 1997; 40: 588-603.
9. Hench LL, Wilson J. Surface active biomaterials. Science 1984; 226: 630-6.
10. Gross V, Brandes J. The ultrastructure of the interface between a glass ceramic and bone. J. Biomed. Mater. Res. 1981; 15: 291-305.
11. Kinnunen I, Aitasalo K, Pollonen M, Varpula M. Reconstruction of orbital floor fractures using bioactive glass. J. Craniomaxillofac. Surg. 2000; 28: 229-34.
12. Peltola M, Suonpaa J, Aitasalo K et al. Experimental follow-up model for clinical frontal sinus obliteration with bioactive glass. Acta Otolaryngol. Suppl. 2000; 543: 167-9.
13. Oonishi H, Kushitani S, Yasukawa E et al. Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin. Orthop. 1997; 334: 316-25.
14. Schrooten J, Helsen JA. Adhesion of bioactive glass coating to Ti6A14V oral implants. Biomaterials 2000; 21: 1461-9.
15. Thompson ID, Hench LL. Mechanical properties of bioactive glasses, glass-ceramics and composites. Proc. Inst. Mech. Eng. 1998; 212: 127-36.
16. Xu X, Huang Z, Wang C. Clinical study of bioactive glass ceramics as orbital implants. Hunan 1 Ko Ta Hsueh Hsueh Pao 1997; 22: 440-2.
17. Cao W, Hench LL. Bioactive materials. Ceramics Int. 1996; 22: 493-507.
18. Schulte M, Schultheiss M, Hartwig E et al. Vertebral body replacement with a bioglass-polyurethane composite in spine metastases: Clinical, radiological and biomechanical results. Eur. Spine J. 2000; 9: 437-44.
19. Jonck LM, Grobbelaar CJ. Ionos bone cement (glass ionomer): An experimental and clinical evaluation in joint replacement. Clin. Mater. 1990; 6: 323-59.
20. Billington RW, Willisams JA. Increase in compressive strength of glass ionomer restorative materials with respect to time. J. Oral Rehabil. 1991; 18: 163-8.
21. Jonck LM, Grobbelaar CJ. Biological evaluation of glass ionomer cement as an interface in total joint replacement. Clin. Mater. 1989; 4: 201-24.
22. Nicholson JW. Glass ionomers in medicine and dentistry. Proc. Inst. Mech. Eng. 1998; 212: 121-6.
23. Brook IM, Hatton PV. Glass-ionomers: Bioactive implant materials. Biomaterials 1998; 19: 565-71.
24. Jonck LM, Grobbelaar CJ. The biological compatibility of glass ionomer cement in joint replacement. Clin. Mater. 1989; 4: 85-107.
25. Wittwer C, Devlin AJ, Hatton PV, Brook IM. The release of serum proteins and dye from glass ionomer and acrylic cements: A pilot study. J. Mater. Sci. 1994; 5: 711-14.
26. Heimke G. Aluminium oxide. In: Williams D (ed.) Concise Encyclopaedia of Medical and Dental Materials. Oxford: Pergamon, 1990; 28-34.
27. Peltier LF, Bickel EY. The use of plaster of Paris to fill defects in bone. Ann. Surg. 1957; 146: 61.
28. Coetzee AS. Regeneration of bone in the presence of calcium sulphate. Arch. Otolaryngol. 1980; 106: 405-9.
29. Bell WH. Resorption rates of bone and bone substitutes. Oral Surg. 1964; 17: 650-7.
30. Hollinger JO, Battistone GC. Biodegradable bone repair materials. Clin. Orthop. 1986; 207: 290-305.
31. Albee FH, Morrison HF. Studies in bone growth, triple calcium phosphate as a stimulus to osteogenesis. Ann. Surg. 1920; 71: 32.
32. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin. Orthop. 1981; 157: 259.
33. Geesink RGT, De Groot K. Bonding of bone to apatite coated implants. J. Bone Joint Surg. Br. 1988; 70: 17.
34. Byrd HS, Hobar PC. Augmentation of craniofacial skeleton with porous hyroxyapatite granules. Reconstr. Surg. 1993; 91: 15-22.
35. Hollinger JO, Brekke J. Role of bone substitutes. Clin. Orthop. 1996; 324: 55-65.
36. Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop. Scand. 2000; 71: 337-53.
37. Bellemans J. Osseointegration in porous coated knee arthroplasty. The influence of component coating type in sheep. Acta Orthop. Scand. Suppl. 1999; 288: 1-35.
38. Strnad Z, Strnad J, Povysil C, Urban K. Effect of plasma sprayed hyroxyapatite coating on the osteoconductivity of commercially pure titanium implants. Int. J. Oral Maxillofac. Implants 2000; 15: 483-90.
39. Hulbert SF, Young FA. Potential ceramic materials as permanently implantable skeletal prosthesis. J. Biomed. Mater. Res. 1970; 4: 433.
40. Klawitter JJ, Bawell JG. An evaluation of bone ingrowth into porous high density polyethylene. J. Biomed. Mater. Res. 1976; 10: 311.
41. Osborn JF, Newesely H. The materials science of calcium phosphate ceramics. Biomaterials 1980; 1: 108-11.
42. Hulbert SF, Klawitter JJ. Tissue reaction to three ceramics of porous and non porous structures. J. Biomed. Mater. Res. 1972; 6: 347.
43. Schoenaers JH, Holmes RE. Healing in interconnected porous hydroxyapatite blocks: Long term histology and histomorphometry. Trans. Soc. Biomater. 1985; 8: 110.
44. Holmes RE, Hagler HK. Porous hydroxyapatite as a bone graft substitute in cranial reconstruction: A histometric study. Plast. Reconstr. Surg. 1988; 81: 662-71.
45. Elsinger EC, Leal L. Coralline hydroxyapatite bone graft substitutes. J. Foot Ankle Surg. 1996; 35: 396-9.
46. Holmes RE. Bone regeneration within a coralline hydroxyapatite implant. Plast. Reconstr. Surg. 1979; 63: 626-33.
47. Bucholz R, Carlton A. Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin. Orthop. 1989; 240: 53-62.
48. Sartoris D, Gershuni D. Coralline hydroxyapatite bone graft substitutes: Preliminary report of radiographic evaluation. Radiology 1986; 159: 133-7.
49. Holmes RE, Mooney V. A coralline hydroxyapatite bone graft substitute. Clin. Orthop. 1984; 188: 252-62.
50. Wolfr SW, Pike L, Slade JF 3rd, Katz LD. Augmentation of distal radial fracture fixation with coralline hydroxyapatite bone graft substitute. J. Hand Surg. (Am.) 1999; 24: 816-27.
51. Zdeblick TA, Cooke ME, Kunz DN, Wilson D, McCabe RP. Anterior cervical discectomy and fusion using a porous hydroxyapatite bone graft substitute. Spine 1994; 19: 2348-57.
52. Boden SD, Martin GJ Jr, Morone M, Ugbo JL, Titus L, Hutton WC. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 1999; 24: 320-7.
53. Georgiadis NS, Terzidou CD, Dimitriadis AS. Coralline hydroxyapatite sphere in orbit restoration. Eur. J. Ophthalmol. 1999; 9: 302-8.
54. Friedman CD, Costantino PD, Synderman CH, Chow LC, Takagi S. Reconstruction of the frontal sinus and frontofacial skeleton with hydroxyapatite cement. Arch. Facial Plast. Surg. 2000; 2: 124-9.
55. Constantz BR, Ison IC. Skeletal repair by in situ formation of the mineral phase of bone. Science 1995; 267: 1796-9.
56. Sanchez-Sotelo J, Munuera L, Madero R. Treatment of fractures of the distal radius with a remodellable bone cement: A prospective, randomised study using Norian SRS. J. Bone Joint Surg. Br. 2000; 82: 856-63.
57. Schildhauer TA, Bauer TW, Josten C, Muhr G. Open reduction and augmentation of internal fixation with an injectable skeletal cement for the treatment of complex calcaneal fractures. J. Orthop. Trauma 2000; 14: 309-17.
58. Yetkinler DN, Ladd AL, Poser RD, Constantz BR, Carter D. Biomechanical evaluation of fixation of intra-articular fractures of the distal part of the radius in cadavera: Kirschner wires compared with calcium-phosphate bone cement. J. Bone Joint Surg. Am. 1999; 81: 391-9.
59. Kopylov P, Runnqvist K, Jonsson K, Aspenberg P. Norian SRS versus external fixation in redisplaced distal radial fractures. A randomised study in 40 patients. Acta Orthop. Scand. 1999; 70: 1-5.
60. Mahr MA, Bartley GB, Bite U, Clay RP, Kasperbauer JL, Holmes JM. Norian craniofacial repair system bone cement for the repair of craniofacial skeletal defects. Ophthal. Plast. Reconstr. Surg. 2000; 16: 393-8.
61. Goodman SB, Bauer TW. Norian SRS cement augmentation in hip fracture treatment. Clin. Orthop. 1998; 348: 42-50.
62. Lotz JC, Hu SS. Carbonated apatite cement augmentation of pedicle screw fixation in the lumbar spine. Spine 1997; 22: 2716-23.
63. Mathias PG, Bostrom MD. Future directions: Augmentation of osteoporotic vertebral bodies. Spine 1997; 22: 38-42.
64. Mundy GR. Regulation of bone formation by bone morphogenic proteins and other growth factors. Clin. Orthop. 1996; 323: 24-8.
65. Oreffo ROC, Triffitt JT. Future potentials for using osteogenic stem cells and biomaterials in orthopaedics. Bone 1999; 25: 5S-9S.
66. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1 positive human bone marrow stromal precursors under serum deprived conditions in vitro. Blood 1995; 85: 929-40.